Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
114.4 BRL | +0.47% |
|
+3.24% | +39.83% |
10/06 | Three companies to bet on medical AI | ![]() |
05/06 | Intuitive Surgical Secures US FDA Approval for Revised da Vinci Xi and X Labeling | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With an expected P/E ratio at 77.81 and 67.21 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+39.83% | 151B | - | ||
+7.77% | 218B | B | ||
+10.16% | 189B | B- | ||
+32.78% | 113B | A- | ||
+0.68% | 64.02B | A- | ||
+14.48% | 52.6B | B+ | ||
+2.92% | 49.85B | B+ | ||
-6.60% | 37.89B | A | ||
-1.07% | 34.92B | - | ||
+23.08% | 31.1B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- ISRG Stock
- I1SR34 Stock
- Ratings Intuitive Surgical, Inc.